Posted on 10/24/2025 by Steven M Smith — Leave a comment

Cannabis and the Endocannabinoid System: The Wonders of CBDs

Updated with PAiNT Research Palette – Green

Co-edited by Steven Smith, PAiNT Research Hemp Is Now A Viable Agriculture Phenomenon Cannabis and the Endocannabinoid System; The Wonders of CBDs CBD Molecule The following is a reprint with updated references. Cannabinoids are the chemical compounds made by the cannabis plant that unlock its many healing secrets. There are over 100 known cannabinoids and these chemicals imitate the endocannabinoids naturally produced in the human body. The shiny little crystals you see on cannabis buds are called trichomes where cannabinoids are stored. Human bodies (and many animals) have endocannabinoid systems (ECS), meaning that cannabinoids are naturally made so they can bind to endocannabinoid receptors creating changes in our physiology. To understand the master gland and immune system of the human body it is crucial to have a basic understanding of the endogenous cannabinoid system, otherwise known as the endocannabinoid system (ECS). The endocannabinoid system is essential to human health because it maintains homeostasis in the body. Research into the endocannabinoid system has increased in recent years as scientists begin to reveal how complex and important this system is to our bodies. The legal cannabis movement started in San Francisco in the early 1990’s when it was discovered that cannabis treated many symptoms that AIDS patients suffered from, including pain. It was medical marijuana laws that changed the legal status of cannabis nationwide, opening the doors for research and an adult-use market and creating a path towards full legalization. Cannabis patients across the country have used the plant to treat a growing number of medical conditions. In Colorado alone, there are nine different qualifying conditions for a medical card: cancer, glaucoma, HIV or AIDS, cachexia (wasting syndrome), persistent muscle spasms, seizures, severe nausea, severe pain, and Post Traumatic Stress Disorder (PTSD).

What Do CBD’s Do? The endocannabinoid system (ECS) is responsible for maintaining homeostasis in the body. Homeostasis is defined as: “any self-regulating process by which biological systems tend to maintain stability while adjusting to conditions that are optimal for survival.” If homeostasis is successful, life continues; if unsuccessful, disaster and ill health ensues. The endocannabinoid system is made up of three parts: cannabinoid receptors, endocannabinoids, and metabolic enzymes. • Endocannabinoid receptors are found throughout the body on the surface of cells in the brain, organs, tissues, and glands. These receptors are embedded in cell membranes and produce varying reactions when stimulated by cannabinoids. • Cannabinoids come from two distinct places — the body, which produces naturally occurring endocannabinoids, and foods like the cannabis plant, which produces phytocannabinoids. • Metabolic enzymes act like a natural referee in that they destroy endocannabinoids once they are used up by the body. The two main metabolic enzymes are fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL). This self-regulating system ensures the interaction of CBDs with the ECS only happens when needed and therefore keeps the workings of the endocannabinoid system relatively quiet to the conscious brain. Because homeostasis is so important to health, all vertebrates and invertebrates are known to have an endocannabinoid system.

Cannabinoids can also be produced synthetically. Marinol (dronabinol) and Cesamet (nabilone) are synthetic versions of THC that have FDA approval to be marketed and sold as a prescription drug. Synthetic cannabinoids do unlock the endocannabinoid system to produce effects, but they often fail to incorporate the entourage effect which states that the sum of the different cannabinoids works better as a whole unit than any cannabinoid individually. With an understanding of the endocannabinoid system and its role in ensuring homeostasis in the body, it may be easier to see how this could be true. The Endocannabinoid System Despite its critical importance, the endocannabinoid system (ECS) was only discovered in the early 1990s when Lisa Matsuda, a researcher at the National Institute of Mental Health, and her colleagues discovered a DNA sequence that defines a THC-sensitive receptor in a rat’s brain. This discovery was quickly followed up with further evidence by Dr. Raphael Mechoulam, the famous chemist who discovered THC. With less than 30 years of research, the endocannabinoid system is one of the least studied systems in the body. Currently, restrictions on cannabis research limit what scientists can examine in terms of furthering the understanding of how cannabis and hemp interact with the endocannabinoid system. Two cannabinoid receptors have been discovered by researchers: CB1 and CB2.

CB1 is found in the central and peripheral nervous system. It’s also found in the brain and is the receptor that THC interacts with, giving the user a “high.” CB2 receptors are predominantly found in the immune system and the gastrointestinal system where they regulate inflammatory responses in the bowels. CB2 receptors are also found in the brain, although not as densely as CB1 receptors. These receptors, a large part of the endocannabinoid system, play roles in regulating cardiovascular activity, appetite, mood, memory, and pain in the body. CBD does not fit exactly into either CB1 or CB2 receptors. CBD stimulates both receptors and causes a reaction without binding directly, creating changes in cells that contain them. CBD also binds to a protein-receptor couple, TRPV-1, responsible for regulating body temperature, pain, and inflammation. CBD is also known for counteracting the effects of THC, activating serotonin receptors, and inhibiting a gene attributed to several cancers. CBD has grown in popularity recently as research and anecdotal evidence increasingly demonstrates the impact it can have on the body. The body’s endocannabinoid system reacts to CB1 and CB2 based upon the organ or bodily system that is sensitive to one or both. The brain is especially sensitive to CB1, the lungs to CB1, the spleen to CB2, the vascular system CB1, the pancreas to CB1 & CB2, the liver to CB1 & CB2, reproductive organs to CB1, the colon to CB2, the muscles to CB1, the immune system to CB2, and the bones to CB2. The endocannabinoid system (ECS) is also involved in regulating a variety of physiological and cognitive processes including fertility, pregnancy (during pre- and postnatal development) appetite, pain-sensation, mood, and memory, and in mediating the pharmacological effects of cannabis. The ECS is also involved in mediating some of the physiological and cognitive effects of voluntary physical exercise in humans and other animals, such as contributing to exercise-induced euphoria as well as modulating locomotor activity and motivational salience for rewards. In humans, the plasma concentration of certain endocannabinoids (i.e., anandamide) have been found to rise during physical activity; since endocannabinoids can effectively penetrate the blood–brain barrier, it has been suggested that anandamide, along with other euphoriant neurochemicals, contributes to the development of exercise-induced euphoria in humans, a state colloquially referred to as a runner’s high. Cannabinoids Cannabinoids are broadly known for their anti-seizure, anti-inflammatory, anti-nausea, anti-fungal, and anti-cancer effects — and science has just scratched the surface. How much these effects are expressed is a result of the entourage effect is not fully known. The entourage effect states that the cannabinoids work better in tandem than they do alone. THC and CBD produce stronger healing properties together that are shown differently based on their concentrations and the presence of other cannabinoids. In addition, terpenes, the oils that give cannabis its fragrance, contribute to the therapeutic effects of the plant on the body when paired with cannabinoids. The powerful combination of these naturally occurring chemicals produces the medical effects that have given cannabis its reputation as a wondrous medical agent.

In California, there are twelve qualifying conditions for a medical cannabis card, including one described as, “any other chronic or persistent medical symptom that substantially limits the ability of the person to conduct one or more major life activities (as defined by the Americans with Disabilities Act of 1990) or, if not alleviated, may cause serious harm to the patient’s safety or physical or mental health.” There are over 100 known cannabinoids and we’ve only briefly described a few. There is a lot more research to be done to understand the intricacies of each cannabinoid and how they interact with each other. Cannabinoids can bind to receptor sites in either the brain (CB-1) or the body (CB-2). Cannabinoids will produce different effects on the body depending on which type of receptor site they bind to. Cannabis strains are filled with multiple cannabinoids that when consumed, bind to these sites, creating a symphony of effects on the body and thus corresponding to the wide variety of healing properties. This is why one plant can treat many different conditions. Cannabinoids begin as cannabinoid acids that are activated when heated. This heat-based activation, also known as decarboxylation, removes the acid from the molecule, turning it into a bioavailable compound that the body can register. The decarboxylated molecule is often more powerful and produces a different effect on the body than the acidic version. This is why you see both “THCA” and “THC” when looking at the contents of a cannabis strain.

🌿 Introduction: A Living System of Discovery The endocannabinoid system (ECS) remains one of the most fascinating regulatory networks in human biology. From mood and sleep to immune balance and pain modulation, the ECS is a master regulator. Cannabinoids like CBD interact with this system in ways that continue to inspire both scientific inquiry and public imagination. With the PAiNT Research Optics Palette – Green, we bring a sharper lens to this evolving field—highlighting not only the breakthroughs but also the blind spots that demand further exploration.

🔬 Current Research Strides

Clinical Expansion: CBD has moved from anecdotal wellness use into formal clinical trials for epilepsy, anxiety, inflammation, and neurodegenerative conditions.
Mechanistic Insights: Researchers are mapping receptor subtypes (CB1, CB2, and beyond), uncovering how cannabinoids influence neurotransmitter release, immune signaling, and vascular health.
Formulation Innovation: Advances in delivery systems—nanoemulsions, transdermal patches, and targeted oral formulations—are improving bioavailability and consistency.
Agricultural Progress: Hemp cultivation under the 2018 Farm Bill has expanded genetic diversity, enabling strains optimized for high-CBD, low-THC production.

⚖️ Current Limitations

Regulatory Barriers: Federal scheduling and fragmented state laws continue to slow large-scale, multi-site clinical trials.
Data Gaps: Long-term safety data, especially for chronic use and polypharmacy interactions, remain incomplete.
Standardization Issues: Variability in plant genetics, extraction methods, and labeling practices undermines reproducibility and consumer trust.
Equity in Access: Research and product development often overlook marginalized communities most affected by health disparities and cannabis criminalization.

🎨 The PAiNT Optics Palette – Green

This editorial lens emphasizes sustainability, wellness, and regenerative potential. “Green” is not only the color of the plant but also a metaphor for growth, balance, and ecological responsibility. Through this palette, PAiNT Research frames CBD and ECS science as part of a broader movement toward integrative health and environmental stewardship.

🚀 Preparing for PAiNT Your Wagon

This blog is the first in a living research series. The next installment, PAiNT Your Wagon, will expand the conversation—exploring how predictive AI, narrative storytelling, and community engagement can accelerate cannabinoid research and policy reform. Together, these pieces will form a living research blog, where each chapter builds on the last, offering readers not just information but a roadmap for advocacy, innovation, and wellness.

✅ Closing Note The ECS is not just a scientific curiosity—it is a bridge between biology, wellness, and culture. By applying the PAiNT Research Optics Palette – Green, we illuminate both the promise and the challenges of CBD research, preparing the ground for deeper inquiry and collective action.

AllRightsReserved-InspirationalTechnologies2024

I hope this information was helpful and informative. If you have any more questions, please feel free to ask me. 😊 Inspirational Technologies – IT is Time

We, at Inspirational Technologies are at the forefront of Inspirational and Frontrunners on the frontier of current technology.

We are often faced with our own personal conflicts which directly influence our interactions with our peers and family.

When Inspirational Technologies is an endorsement of the “Cannabis” approach to the medical condition, we say, let’s let the look at the data and the people who say that they benefit for cannabis alternatives.

At Inspirational Technologies

Our mission is to shape public perception and policy through credible, engaging narratives that empower communities. With the PaiNT Network, we are extending that mission into the realm of predictive intelligence. By blending editorial rigor with AI foresight, we are creating a platform that doesn’t just inform—it inspires action.

As Steven Smith notes:

Looking Ahead The launch of PaiNT Research is only the beginning. In the coming months, Inspirational Technologies will:

• Roll out “Engage → Palette” cycles on our blog, showing how dialogue evolves into curated insights. • Publish “PaiNT Your Wagon” action briefs to guide policymakers and advocates. • Release “PaiNT You a Picture” visuals to make complex science accessible. • Amplify insights through “PaiNT the Town”, ensuring that predictive intelligence reaches the audiences who need it most.

A Call to Collaboration We believe that predictive intelligence is not a solitary pursuit—it is a collective canvas. Every voice adds a brushstroke. Every perspective adds depth. Together, we can paint a future where research is not just conducted but understood; not just published but lived. Join us as we launch PaiNT Research. Explore the categories. Share your insights. Because the future is not something we wait for—it’s something we paint together.

Brought to you by the PaiNT Network (2025) an inspiration from Inspirational Technologies

Predictive Artificial Intelligence News & Technology 2025

=====================================================================================================================================

We, at Inspirational Technologies are at the forefront of Inspirational and Front runners on the frontier of current technology. ___________________________________________________________________________________________________All Rights Reserved – Inspirational Technologies 2025 We hope this information has been helpful and informative. Don’t hesitate to reach out with any further questions. 😊

Predictive Artificial Intelligence News & Technology

1st Hemp USA News is a resource of Inspirational Technologies (2021)

Logo by Steven M Smith Created 3/1/2014

Posted on 10/03/202510/04/2025 by Steven M Smith — Leave a comment

Farm Bill 2025 overview

Farm Bill 2025 overview

The Farm Bill is reauthorized roughly every five years and covers commodity supports, crop insurance, conservation, nutrition (e.g., SNAP), rural development, research, forestry, and more allocating both mandatory and discretionary funding across programs that touch every state and community. Congress extended the 2018 Farm Bill through September 30, 2025, via the American Relief Act of 2025, providing short-term continuity while leaving several programs without permanent baselines unfunded. Debate in 2025 has been shaped by the “One Big Beautiful Bill Act” (OBBBA), a reconciliation law that addressed many farm bill-related provisions but left key issues unresolved as the farm bill officially expired on September 30, 2025.

InspirationalTech.org

Table of contents-style breakdown (high-level)

This mirrors how Farm Bill titles are typically organized and debated, not the final statute text.

Commodity programs: ARC, PLC, marketing loans, payment limits, eligibility.
Crop insurance and risk management: Federal crop insurance structure and premium support.
Conservation: Working lands (e.g., EQIP, CSP), easements, climate resilience.
Nutrition: SNAP eligibility, benefits, Thrifty Food Plan updates, QC and waivers.
Rural development: Broadband, energy, water, housing programs.
Forestry: Wildfire mitigation, restoration, timber markets.
Research and extension: Land-grant capacity, competitive grants, data systems.
Trade and food aid: Export market development, international food assistance.
Specialty crops and organics: Grants and cost-share; note several “orphaned” organic programs lack baseline funding under the extension.
Disaster assistance: Permanent and ad hoc aids for extreme weather.

A broad explainer confirms this scope; the current one-year extension kept major baseline programs running while leaving non-baselined “orphaned” efforts—such as certain organic initiatives—unfunded.

Basic breakdown of major 2025 dynamics

Extension and uncertainty: The 2018 Farm Bill was extended through September 30, 2025, averting immediate disruption but frustrating stakeholders due to limited reforms and selective funding. Baseline programs like ARC, PLC, and DMC continued; several organic initiatives did not due to absent baselines.
Reconciliation overlap (OBBBA): OBBB addressed about 80% of farm bill-related provisions, including commodity programs, crop insurance, and tax policy, but left key areas unresolved as the farm bill expired, increasing policy uncertainty for producers.
Commodity support changes: The reconciliation law increased support levels for PLC, ARC, and commodity marketing loans, adjusted payment limits and eligibility starting with the 2025 crop year, and provided for new base acres beginning in 2026.
Nutrition program changes (SNAP): OBBB modified SNAP, including limiting future Thrifty Food Plan (TFP) reevaluations, setting annual TFP adjustments each October to reflect CPI-U, and altering able-bodied adults without dependents (ABAWD) time-limit exceptions and waiver rules; USDA indicated effective dates and a QC “hold harmless” period for states.
Political landscape: Deep, partisan divisions—especially over SNAP cuts advanced through reconciliation—complicate the path to a bipartisan farm bill reauthorization, according to industry voices tracking the debate.

Implementation timetable

Milestone	What happens	Who’s affected
Through Sep 30, 2025	One-year extension of 2018 Farm Bill programs (ARC, PLC, DMC, disaster assistance); some non-baselined programs lapse	Producers, USDA program administrators
2025 crop year (immediate)	Higher support levels for PLC/ARC and marketing loans; revised payment limit/eligibility rules begin	Covered commodity producers
2026	Addition of new base acres under reconciliation law provisions	Eligible producers in qualifying areas
Oct 1, 2025	SNAP: TFP annual CPI-U adjustment schedule takes effect; other OBBB SNAP changes begin per USDA guidance	States, SNAP households
No earlier than Oct 1, 2027	Next eligible TFP market basket reevaluation window	USDA, states
First 120 days post-implementation	USDA QC “hold harmless” for states implementing new SNAP provisions	State SNAP agencies

Sources:

Relation to state bills and administration

Nutrition (SNAP) alignment: States will implement OBBB SNAP changes, including new TFP adjustment mechanics and updated ABAWD exceptions (e.g., raising upper age to 65, revising caregiver exception to under-14 dependents, removing certain exceptions while adding others for specified American Indian categories). USDA’s QC “hold harmless” for 120 days supports transition, while waiver approval criteria shift, affecting state-level time-limit waivers and caseload administration.
Agriculture program uptake: Commodity program changes (support level increases, eligibility rules, base acres in 2026) are federally administered but require producer enrollment through state-level USDA offices (FSA/NRCS), influencing how state agriculture departments coordinate outreach, compliance, and disaster reporting tied to federal programs.
Budget and program continuity: The one-year extension stabilized baseline programs through September 2025, but absence of baselines for select organic initiatives (e.g., OCCSP, ODI) means states and producers relying on those supports may need interim state legislation or alternative funding to bridge gaps until federal reauthorization restores or reforms them.

Final summary and strategic outlook

The 2025 landscape is a hybrid: a stopgap extension to September 30, 2025, overlaid with reconciliation-driven changes that lift commodity supports and reshape SNAP mechanics, while leaving unresolved gaps and political friction that delay a comprehensive reauthorization. Near-term focus for producers and states is on enrolling under the updated commodity rules for the 2025 crop year, preparing for new base acres in 2026, and implementing SNAP adjustments with USDA’s transitional safeguards. For advocacy and communications—especially in wellness, agriculture, and hospitality—this moment calls for precise, data-forward messaging: emphasize continuity where secured, name gaps transparently, and guide stakeholders toward enrollment windows, compliance checkpoints, and state-level bridges until a full Farm Bill is enacted.

The farm bill includes hemp programs under the USDA, though this isn’t widely cited in sources. There’s a general note that state legislatures could align with crop disaster assistance, workforce rules, and SNAP waivers impacted by Section 6(o).

=====================================================================================================================================

We, at Inspirational Technologies are at the forefront of Inspirational and Frontrunners on the frontier of current technology.

___________________________________________________________________________________________________

We hope this information has been helpful and informative. Don’t hesitate to reach out with any further questions. 😊

Posted on 10/02/2025 by Steven M Smith — Leave a comment

Inspirational Technologies presents the Hemp Story “MISUNDERSTOOD”

Inspirational Technologies presents the Hemp Story “MISUNDERSTOOD” – Read it and REAP then Weep (2025)

Be determined to help us make the planet a better place by supporting our mission to inform and educate the public about the many benefits ‘hemp’ once brought to our daily lives. Take the time to learn how hemp can contribute to positive changes in our future. We hope you’ll be inspired by hemp and the shared future we can create together. Thank you for your support. Steven M. Smith, Inspirational Technologies, dedicated to your health, wellness, and beauty since 2014. The following Hemp Story is rewritten from its’ original post in 2019.

Thank You for your continued support of Inspirationaltech.org

A forbidden fiber in the U.S. since 1970, hemp has taken the heat for almost five decades. Until the Farm Bill passed in December of 2018, hemp was federally illegal to grow for commercial purposes, making it risky for businesses to invest in a new crop that was incorrectly classified as a drug. Imagine a sweater softer than any fabric you’ve ever felt before, and more durable than cotton. Imagine a car built with something lighter than steel that could stand 10 times the impact without denting.

Imagine if you could save four acres of trees by making paper with 1 acre of hemp. Imagine biodegradable Legos.

Now imagine all this possibility actually exists but you can’t enjoy any of it because people in power once decided the plant from which it’s all derived has a scorned cousin named “marijuana.”
If you can wrap your mind around this dereliction of logic, only then can you begin to understand the painfully silly policies America’s had in place that have kept hemp from coating our farmland with hues of pale yellow and light green. That longstanding logic has been costly for our country. United States’ hemp prohibition has suppressed potential jobs for farmers, products for consumers, and medicine for patients.

Cousin or not, the reality is, hemp can’t get you high just as near beer can’t get you drunk. Despite all that–and while near beer takes up three spots in every Walmart in America– hemp has been largely banned in the United States, until now.
To understand the differences between hemp and marijuana it’s critical to know what each distinctly different plant is capable of doing. The Ministry of Hemp offers the most comprehensive and easily digestible explanation of hemp versus marijuana. The 2018 Farm Bill: How we got here. Here’s what happened. Way back when, an angry and lobby-influenced Congress passed the Marihuana Tax Act of 1937, which effectively outlawed the possession of cannabis—including hemp—after hundreds of years of growth and use from the time of British colonization onward. While that law was repealed in the late 1960s, cannabis was quickly included as a Schedule 1 drug (the most “dangerous” class of drugs including heroin) in the Controlled Substances Act, a designation which continues to this day.

After 81 years, the 2018 Farm Bill represents the largest step towards undoing the racist and scientifically baseless legacy of the Marihuana Tax Act of 1937.

The 2018 Farm Bill officially reclassifies hemp for commercial uses after decades of statutes and legal enforcement conflating hemp and marijuana, the Farm Bill distinguishes between the two by removing hemp from the Controlled Substances Act. (While the two are closely related, hemp lacks the high concentration of THC that is responsible for the high from smoking marijuana.) This would effectively move regulation and enforcement of the crop from the purview of the Drug Enforcement Agency to the U.S. Department of Agriculture.

The 2018 Farm Bill expands upon provisions in the 2014 version of the annual bill, which created Hemp Pilot Programs. These Hemp Pilot Programs “created a framework for the legal cultivation by states of ‘industrial hemp’ without a permit from the Drug Enforcement Administration.” The 2014 Hemp Pilot Programs were a success for farmers and consumers across the U.S., from Colorado to North Carolina.
Senate Majority Leader Mitch McConnell continues to be ardently anti-marijuana, despite the success of these programs and the fact that 62% of Americans say recreational marijuana should be legal. Nevertheless, McConnell and Senate Republicans read the political tea leaves and will now recognize the important differences between marijuana and hemp. In doing so, they’re creating an exciting time for entrepreneurs, CBD advocates, and farmers across the country. US previous administration trade wars were hurting farmers to the tune of billions of dollars. Wheat, soybean, and corn farmers have been targeted by China as the potent measure in its escalating tariff battle with the U.S. In 2017, China imported more than $24 billion in agriculture products from the U.S. The world’s top wheat consumer, China and purchased 1.6 million tons of U.S. wheat worth $391 million. At the same time, China bought $14 billion in soybeans for personal and animal consumption from the U.S. last year–more than any other agricultural commodity, and the country’s corn imports from the U.S. were worth $160 million.

All that’s changed with the high trade tariffs Trump’s levied on countries who import our products. Analysts and existing evidence suggest the soybean trade conflicts will be in favor of fellow exporters, Brazil and Argentina, rather than the U.S. The tariff could drop China’s imports of soybeans by 69% on average. The estimated effect of China’s 25% tariff on U.S. soybean imports would cut income for a midsize Illinois grain farm by an average of 87% over four years, prompting a loss of more than $500,000 in the farm’s net worth by 2021. It’s a messy situation. Trump needed a win, and farmers did too. Distinguishing between commercial hemp and marijuana, legalizing the former, is that much-needed reprieve. “We’re so pleased farmers across America now have the freedom to consider integrating this important crop into their production, particularly with the trade concerns around other crops such as soybeans, corn, and wheat,” said Elizabeth Hogan, VP of Brands at GCH Inc., the company behind Willie Nelson’s cannabis brands. Hemp legalization will transform it from niche interest and return it to cash crop status.

Hemp is a farmer’s friend because compared with cotton, corn, and soybeans, it requires little water, isn’t picky when it comes to poor soil. It grows tightly spaced, thus crowding out weeds, and boasts a deep, soil-aerating root system. Despite all its advantages, and because growing it is illegal with the exception of limited licenses, the U.S. imports approximately $60 million worth of hemp from overseas countries like China. Political leverage This Farm Bill gave Trump Administration a powerful tool in their bargaining with China. As I wrote earlier this year in Forbes, China produces 50% of the world’s cannabis supply, with a large majority of that supply being the THC-lacking hemp variety; this gives China “massive economic potential” which “poses a threat to cannabis interests around the world and particularly in the U.S. market.”

Studies at Bejing’s Hemp Research Center revealed the variety of plant uses, prompting China to expand its hemp production which is a mere fraction of its world-leading cotton production. China not only has the product, but they have the cultivation techniques and commercial technologies to capitalize on that supply. And they are ramping up to leverage their competitive hemp advantage, expecting an eager demand from U.S. manufacturers given hemp’s rise in popular applications. By contrast, U.S. farmers grew merely 25,000 acres of hemp in the entire country in 2017. To give that context, that’s the same amount of land Bill Gates bought in Arizona to create a small, futuristic city.

That’s cool for a retirement project if you’re a billionaire, but hardly enough land to launch any sort of industry. And of that, about 70% of which was used to make CBD oil. Only recently have we seen an increase in manufacturers using hemp fibers to make fabrics, construction materials, health products, and other consumer goods.

With the passage of the 2018 Farm Bill, America will have a chance to counter China’s massive influence in the cannabis hemp industry. But it will mean playing catch-up for the foreseeable future. Currently, hemp cultivation techniques in America lag far behind other crops—it still has to be harvested by hand even. Even though marijuana is legal in China, the country has funded research into the plant and its cultivation, placing it miles ahead of other countries. The Farm Bill will help hemp farmers and entrepreneurs.

The 2018 Farm Bill will radically overhaul America’s relation to hemp and could unleash a hemp renaissance in the coming years that will close the gap between the U.S. and China. As a Schedule 1 substance alongside marijuana, hemp farmers and entrepreneurs in the U.S. have faced many barriers to doing business. Interstate commerce for hemp products was almost non-existent and financing was difficult to come by. But all that is set to change.

According to the American Agriculturist, the 2018 Farm Bill will allow hemp to be regulated by the USDA, including the labeling of American-grown hemp as certified organic; interstate hemp commerce will be legalized; financing and research opportunities will open up; hemp farmers will be guaranteed water rights; the definition of hemp will be altered to make it a non-drug commodity.

Hemp has hundreds of uses, many of which are yet to be discovered or fully realized thanks to the lack of available research funds. From textiles and plastics to livestock feed and home cooking, hemp has many applications that can reduce our dependence both on other countries and fossil fuels. Driven by explosive growth in hemp-based consumer products, the global hemp market is expected to jump to $10.6 billion by 2025.

Everything from our vodka to our cars is waiting to be reimagined in the future with legal hemp. Many people won’t even realize how much their lives are affected by cannabis-based products. One of the most exciting applications of hemp lies in the extracted cannabinoids or CBD oil. According to the Washington Post, “dozens of studies have found evidence that the compound can treat epilepsy as well as a range of other illnesses, including anxiety, schizophrenia, heart disease, and cancer.” With the legalization of hemp, CBD can be regulated and researched much more than before to truly understand the medical efficacy for a wide range of diseases.

“We continue to see great progress towards a new perspective on cannabis within the US. Within healthcare, several conditions and certain patient profiles rely heavily on CBD-only products of which the proposed Farm Bill will work to dramatically improve access to patients – not only in the US but globally,” said Prad Sekar, CEO of CB2 Insights in a written interview. All of those uses make hemp a profitable cash crop for suffering farmers, with some early commercial growers reporting $100 per-acre more profit on hemp than canola. Hemp grown for CBD oil, on the other hand, can take in $8,000 per acre versus $600 per acre for corn. In particular, hemp can be a boon for arid western states. According to Pacific Standard,

Hemp is thus profitable and sustainable, two words which have eluded many U.S. farmers as of late. Hemp cultivation could provide much-needed relief as farmers struggle to find markets for millions of bushels of crops during the trade wars. Now, instead of importing an estimated $100 million of hemp products every year, that money will go to American farmers and entrepreneurs.

Bruce Perlowin, CEO of Hemp, Inc, believes hemp legalization will drive disenfranchised farmers “back-to-the-land” now that they’ll have a solid economic basis in industrial hemp to rely on. “Our strategy has been to partner with farmers across the country in states where hemp cultivation and manufacturing is legal to provide them with the infrastructure needed to make a profit off this incredible crop, and this bill will be an incredible boon for the American small family farm,” Perlowin continued “The health and wellness industries are in for a major overhaul with the massive research and development and exploration into CBD‘s, CBGs, CBN’s and 113 other cannabinoids as well as some 300 terpenes found in the industrial hemp plant.”

AllRightsReserved-InspirationalTechnologies2024

What developments have occurred since the signing of the 2018 Farm Bill,

especially regarding how individual states are addressing issues related to CBD and Kratom?

Since the 2018 Farm Bill, states have rapidly evolved their regulations on CBD—especially hemp-derived intoxicants—

and are beginning to address Kratom with increasing scrutiny and legislative action.

🧪 CBD: From Wellness to Regulatory Whiplash
Federal Shift (2018–2025):
• The 2018 Farm Bill legalized hemp (≤0.3% delta-9 THC), opening the door for CBD products nationwide.
• However, it inadvertently created a loophole for intoxicating hemp derivatives like delta-8 THC, delta-10, and THCa, which are chemically altered but still derived from legal hemp.
• The FDA has not approved CBD as a dietary supplement or food additive, leaving states to fill the regulatory vacuum.
State-Level Responses:
• Early years (2018–2022): Most states treated hemp-CBD as a wellness product, with minimal oversight.
• By 2023: Only 8 states had rules addressing intoxicating hemp derivatives.
• By mid-2025: Over 40 states now regulate or ban hemp-derived intoxicants. These laws include:
• Potency limits and age restrictions
• Licensing and testing requirements
• Labeling rules (QR codes, batch IDs, warnings)
• Bans on chemical conversion processes used to create synthetic cannabinoids
Examples:
• California allows CBD in foods/beverages but restricts intoxicating hemp.
• New York enforces age limits, serving caps, and QR-linked COAs.
• Texas permits food/supplement formats with strict labeling; smokable hemp is restricted.
• Indiana pioneered QR-code traceability and batch testing.

🌿 Kratom: A Rising Focus
While Kratom wasn’t addressed in the 2018 Farm Bill, its growing popularity has prompted state-level action:
• Some states (e.g., Alabama, Arkansas, Indiana) have banned Kratom outright due to concerns over addiction and safety.
• Others (e.g., Florida, Georgia, Utah) have passed Kratom Consumer Protection Acts, which regulate:
• Minimum age for purchase
• Labeling and purity standards
• Prohibitions on adulterated or synthetic Kratom
This patchwork reflects rising public health concerns and a push for consumer safety without federal oversight.

We, at Inspirational Technologies are at the forefront of Inspirational and Frontrunners on the frontier of current technology.

We are often faced with our own personal conflicts which directly influence our interactions with our peers and family.

___________________________________________________________________________________________________

We hope this information has been helpful and informative. Don’t hesitate to reach out with any further questions. 😊

Posted on 09/27/2025 by Steven M Smith — Leave a comment

A Decade of Hemp Innovation: Inspirational Technologies’ Journey and Next Chapter

Year/Period	Major Milestones	Future Goals
2013	Founding: Steven Smith establishes Inspirational Technologies in Florida with a mission to merge natural wellness and advanced science. Begins research into hemp and medicinal herbs.	Global Health Impact: Leverage hemp compounds to improve lives worldwide, bridging nutraceuticals and pharmaceuticals.
2014	First Investment & Website Launch: Secures initial private funding. Launches InspirationalTech.org as an educational hub to share research and combat misconceptions about hemp.	Educational Leadership: Continue to educate consumers and health professionals about cannabinoids, setting industry standards for transparency.
2015	Research Foundations: Early lab studies on hemp compounds suggest potential benefits (anxiety reduction, anti-inflammatory effects). Establishes academic collaborations to validate findings.	Research & Development: Invest in clinical trials and R&D for new cannabinoid therapies (e.g., pain, anxiety, neuroprotection), turning promising research into approved treatments.
2016–2017	Focus on CBD & Product Prototypes: Pivots to focus on hemp-derived CBD as interest grows. Develops first CBD product prototypes (topical cream and tincture) blending botanical science with tech.	Product Innovation: Develop next-gen products (e.g., multi-cannabinoid formulas, improved delivery systems like patches or nano-emulsions) for more effective relief.
2018	Regulatory Breakthrough: U.S. Farm Bill 2018 legalizes hemp federally [What Does…usinesses?], [What Does…usinesses?], removing major legal barriers. Inspirational Tech poised to enter the national market with tested products.	Quality & Compliance: Lead in product quality, exceeding regulatory requirements. Work with regulators (FDA, etc.) to establish clear guidelines that ensure consumer safety and trust.
2019	Product Launch & hempSMART Partnership: Launches first retail products nationwide. Partners with hempSMART to expand reach and co-develop offerings, boosting brand visibility and distribution.	Strategic Partnerships: Build new alliances (with wellness companies, research institutes, healthcare providers) to expand globally and integrate hemp solutions into mainstream wellness and medicine.
2020–2021	Rapid Growth: Surges in customer adoption amid rising CBD popularity. Expands team and facilities; recognised in industry for science-driven approach. U.S. CBD use jumps (33% of Americans by 2020) despite lingering stigma.	Market Expansion: Enter new markets in Europe, Canada, and Asia as global hemp legalization progresses. Continue to adapt to market trends and consumer needs with agility.
2022	Industry Leadership: Establishes itself as a leading hemp innovation company. By 2022, U.S. CBD sales reach $1.9B [CBD Statis…bes Health] and 60% of adults have tried CBD [CBD Statis…bes Health] – a testament to growing acceptance that Inspirational Tech helped foster.	Industry Leadership & Advocacy: Influence the hemp industry’s evolution by advocating for sustainable practices, environmental responsibility in cultivation, and social responsibility in marketing (ensuring products are used appropriately for wellness).
2023	New Initiatives: Kicks off new R&D projects on cannabinoids like CBG/CBN for pain and sleep. Prepares for clinical collaborations to formally study cannabinoid therapies. Company culture shifts toward biotech startup mindset (hiring medical liaisons, data scientists).	Therapeutic Breakthroughs: Aim to achieve at least one FDA-approved cannabinoid therapy in the next 5–7 years, bringing a natural yet scientifically-vetted medicine to patients (e.g., a prescription CBD/CBG pain reliever).
2024	Preparation for New Direction: Aligns strategy with market trends and scientific advances. Strengthens compliance team for anticipated regulations. Engages with lawmakers on CBD policy. Concepts for personalized cannabinoid wellness programs (leveraging AI) in development.	Personalized Wellness: Utilize technology (AI and data analytics) to tailor cannabinoid-based solutions to individual needs, ushering in an era of personalized, plant-based medicine.
2025 & Beyond	Announcing New Direction: Unveils a forward-looking strategy focusing on advanced research, broader health applications, and global expansion. Poised to integrate hemp-based innovation into healthcare on a larger scale, staying true to the vision of holistic wellness powered by science.	Vision 2030: By 2030, become a global pioneer in cannabinoid science, with a portfolio spanning consumer health products, licensed medical treatments, and technological platforms – all while maintaining the trust and holistic principles that have defined Inspirational Technologies since 2013.

We hope this information has been helpful and informative. Don’t hesitate to reach out with any further questions. 😊

Inspirational Technologies – IT is Time

At Inspirational Technologies, we take pride in being pioneers and innovators in the constantly evolving world of technology.

Life often presents personal challenges that shape our relationships with family and peers.

Steven M. Smith, CEO of InspirationalTech.org since 2013.

Thank you for considering Inspirational Technologies.

Visit InspirationalTech.org to explore your health, wellness, beauty, and inspirational goals.

Discover more about Cannabis, CBD, and YOU.

Posted on 09/09/202509/20/2025 by Steven M Smith — Leave a comment

More than a Decade of Innovation: Inspirational Technologies (2013–2025)

February 14, 2013, Inspirational Technologies

🌱 More than a Decade of Innovation: Inspirational Technologies (2013–2025)

Founded in 2013 by visionary entrepreneur Steven Smith, Inspirational Technologies emerged with a bold mission: to explore the intersection of natural wellness and cutting-edge science. From its humble beginnings to its current position as a thought leader in hemp-based innovation, the company’s journey has been marked by resilience, discovery, and a relentless pursuit of purpose.

🚀 2013–2015: Laying the Groundwork

Inspirational Technologies began as a small research-focused startup headquartered in Florida. Steven Smith, with a background in plant sciences and a passion for holistic health, envisioned a company that could bridge traditional botanical remedies with modern technology.

Initial Focus: The early years were dedicated to foundational research in plant-based compounds, particularly those found in hemp and other medicinal herbs.
Challenges: Regulatory uncertainty around cannabis-related research posed significant hurdles. Funding was limited, and public perception of hemp was still clouded by its association with marijuana.
Successes: Despite these obstacles, the company secured its first private investment in 2014 and launched its website, , as a hub for educational content and research updates.

🌿 2016–2018: Expanding into Hemp and Cannabinoids

As public interest in cannabidiol (CBD) began to surge, Inspirational Technologies pivoted toward deeper exploration of hemp-derived cannabinoids.

Research Milestones: The company initiated studies on CBD’s potential for anxiety, inflammation, and neuroprotection. Collaborations with academic institutions helped validate early findings.
Product Development: By 2017, Inspirational Technologies had developed prototypes for CBD-infused wellness products, including topical creams and tinctures.
Obstacles: The lack of federal clarity on hemp legality made distribution and marketing difficult. Several promising partnerships fell through due to legal concerns.
Breakthroughs: In 2018, as a subsidiary of a company that successfully patented a proprietary extraction method that preserved the full spectrum of cannabinoids while eliminating THC—a major step toward compliance and consumer safety was evolving.

🌾 2019: The Farm Bill Revolution

The passage of the 2018 Farm Bill, which went into effect in early 2019, was a watershed moment for Inspirational Technologies and the hemp industry at large.

Legal Clarity: The bill federally legalized hemp (defined as cannabis with less than 0.3% THC), opening the floodgates for research, cultivation, and commerce.
Strategic Expansion: Inspirational Technologies quickly scaled operations, partnering with licensed hemp farms across the southeastern U.S. to ensure a steady supply of high-quality raw material.
New Ventures: The company launched its flagship product line—“Inspire Naturals”—featuring CBD oils, capsules, and skincare products. These were met with enthusiastic reception in wellness communities.
Educational Outreach: Steven Smith spearheaded a national campaign to educate consumers and healthcare providers about the differences between hemp-derived CBD and marijuana, emphasizing safety, efficacy, and legality.

Paula Vetter
Certified Paula Vetter is a Holistic Family Nurse Practitioner with more than 30 years of experience in both Traditional and Functional Medicine. She is also a Certified Herbalist and Energy Medicine Practitioner. Paula was a Critical Care Instructor at the prestigious Cleveland Clinic for more than a decade, taught at two Ohio colleges, and did primary care in a busy Family Practice in NE Ohio.

🧪 2020–2021: Deepening Scientific Inquiry

With hemp now mainstream, Inspirational Technologies doubled down on research and development.

Cannabinoid Research: The company expanded its focus beyond CBD to lesser-known cannabinoids like CBG (cannabigerol), CBC (cannabichromene), and CBN (cannabinol), investigating their unique therapeutic properties.
Clinical Trials: In 2020, the company launched its first human trial studying the effects of a CBD-CBG blend on chronic pain and sleep disorders. Preliminary results showed promising improvements in sleep quality and reduced reliance on opioids.
COVID-19 Impact: The pandemic disrupted supply chains and delayed several research initiatives. However, it also heightened interest in immune-supportive and stress-reducing supplements, boosting sales of CBD products.
Digital Transformation: was revamped to include interactive tools, webinars, and a cannabinoid knowledge base, making it a go-to resource for consumers and researchers alik

2021 Inspirational Technologies

🌐 2022–2023: Advocacy, Innovation, and Global Reach

As the hemp industry matured, Inspirational Technologies evolved into a multifaceted enterprise with global ambitions.

International Collaborations: The company partnered with European and Canadian firms to explore cross-border cannabinoid research and product distribution.
Sustainability Initiatives: Recognizing hemp’s environmental benefits, Inspirational Technologies began investing in regenerative agriculture and biodegradable packaging.
Advocacy Work: Steven Smith became a vocal advocate for clearer FDA regulations on CBD, testifying before congressional panels and contributing to policy white papers.
Obstacles: Regulatory delays continued to hamper progress. The FDA’s slow movement on CBD guidelines created uncertainty for retailers and investors.
Successes: Despite these challenges, the company’s revenue tripled between 2021 and 2023, driven by its diversified product portfolio and growing brand loyalty.

🔬 Scientific Legacy and Future Vision

Twelve years in, Inspirational Technologies stands as a beacon of integrity and innovation in the hemp space. Its contributions to cannabinoid science have helped shift public perception and pave the way for safer, more effective natural therapies.

Research Highlights:
- Discovery of synergistic effects between CBD and CBG in managing inflammation.
- Development of nano-emulsified CBD for enhanced bioavailability.
- Ongoing studies on cannabinoids and neurodegenerative diseases.
Vision for the Future:
- Expand into personalized cannabinoid therapies using AI-driven health assessments.
- Launch a nonprofit arm to support underserved communities with access to hemp-based wellness.
- Continue advocating for science-based regulation and consumer protection.

🌟 Conclusion

From a fledgling startup navigating legal gray areas to a respected leader in hemp innovation, Inspirational Technologies has charted a remarkable course. Steven Smith’s unwavering belief in the power of nature and science has fueled a decade of breakthroughs, setbacks, and triumphs. As the world continues to embrace plant-based wellness, Inspirational Technologies is poised to inspire the next generation of cannabinoid research and holistic health.

We hope this information has been helpful and informative. Feel free to reach out if you have any further questions. 😊

Inspirational Technologies – IT is Time

At Inspirational Technologies, we pride ourselves on being pioneers and innovators in the ever-evolving world of technology.

We often encounter personal challenges that shape our relationships with peers and family.

Steven M. Smith, CEO of InspirationalTech.org since 2013.

Thank you for considering Inspirational Technologies. Visit InspirationalTech.org for your health, wellness, beauty, and inspirational goals. Learn more about Cannabis, CBD, and YOU.

Steven M Smith InspirationalTech.org CEO since 2013.

Thank you for consideration.

September 19, 2025

InspirationalTech.org for your Health Wellness Beauty and Inspirational Goals

4 Hemp Club was inspired by Steven Smith’s vision:

“Create an older generation 4H Club where adults continue the legacy of the younger 4H Club.

Our platform uses Hemp as a focal point for agriculture, research, and development, emphasizing

Health, Hope, and Happiness through Hemp.”

*This site operates with minimal compensation for product sales. Humanitarian values are prioritized over monetary gains. Income supports research, development, discovery, and healing.

Inspirational Technologies is committed to your health, wellness, beauty, and enrichment.
Reporting on today’s botanical and skincare product benefits.

🌱 General Wellness & Natural Healing
• #NaturalHealing
• #HolisticHealth
• #PlantBasedWellness
• #NatureKnowsBest
• #GreenMedicine
• #HealingWithPlants
• #EarthGrownRemedies
• #BotanicalBenefits
• #WellnessJourney
• #MindBodyBalance
💆 Pain, Inflammation & Recovery
• #PainRelief
• #AntiInflammatory
• #MuscleRecovery
• #JointSupport
• #ChronicPainHelp
• #SoothingRelief
• #CBDForRecovery
• #HempHealing
• #PostWorkoutRelief
• #NaturalPainManagement
😌 Mental Health & Stress Relief
• #AnxietyRelief
• #StressSupport
• #CalmNaturally
• #MentalWellness
• #CBDForAnxiety
• #RelaxWithCBD
• #MoodSupport
• #PeaceOfMind
• #EmotionalBalance
• #CBDForCalm
😴 Sleep & Rest
• #BetterSleep
• #CBDForSleep
• #RestWell
• #SleepSupport
• #NaturalSleepAid
• #SweetDreamsCBD
• #DeepRest
• #CBDNightRoutine
• #RelaxAndRecharge
• #SleepNaturally
🧠 Brain & Body Benefits
• #NeuroSupport
• #BrainHealth
• #CBDForFocus
• #EndocannabinoidSystem
• #CannabinoidCare
• #CBDScience
• #BodyBalance
• #CBDWellness
• #HempPower

Posted on 08/04/202408/05/2024 by Steven M Smith — Leave a comment

Can CBD Improve My Health and Wellness?

Oil, gummies and what you should know.

The global cannabidiol, or CBD, market is exploding, with analysts projecting it will hit 22.05 billion by the year 2030. That’s nearly 20% of the size of the global soft drinks market even though CBD was only legalized in the U.S. in 2018 while the soda market has existed here for nearly 200 years.

In a few short years, CBD products have sprouted up everywhere and are available for purchase in the form of oils absorbed on one’s tongue, edibles such as gummies, candies, foods, pills or beverages, topical applications of ointments, creams or lotions absorbed on one’s skin, and inhalation by vaping or smoking.

What is CBD?

CBD is a chemical compound largely derived from hemp in the cannabis (marijuana) sativa plant. The plant has over 85 chemicals that are identified as cannabinoids, but cannabidiol is the most frequently used one for medical purposes due to its lack of psychoactive effect.

There are three main types of CBD:

full-spectrum CBD, which contains all beneficial compounds naturally found in the cannabis plant;
broad-spectrum CBD, which contains only some such compounds;
and CBD Isolate or “pure CBD,” which doesn’t contain any delta-9-tetrahydrocannabinol, or THC, nor any other compound from the hemp plant.

Legally, no CBD products can contain more than 0.3% (by dry weight) of THC, the mind-altering substance in marijuana known for its psychoactive effects.

Because of this, “CBD is not intoxicating and will not make you high” as some people believe, explains Janice Newell Bissex, MS, RDN, FAND, holistic cannabis practitioner at Jannabis Wellness. Instead, “CBD interacts with our endocannabinoid system,” she says. One’s endocannabinoid system (ECS) is a widespread neuromodulatory system that “plays a role in regulating pain, mood, immune function and inflammation,” says Josh Redd, NMD, the founder of RedRiver Health and Wellness and author of “The Truth About Low Thyroid.”

What does CBD do?

In this interaction with one’s endocannabinoid system, the chemical compound works to calm one’s nervous system, reduce inflammation and alleviate some chronic pain symptoms. Harvard Medical School says “there is moderate evidence that CBD can improve sleep disorders, fibromyalgia pain, muscle spasticity related to multiple sclerosis and anxiety.”

Bissex adds that some people find that CBD can also be a helpful treatment for traumatic brain injuries or seizures. Redd says the chemical compound has properties that can alleviate some epilepsy symptoms and provide autoimmune management as well.

Is CBD considered a drug?

Though CBD does affect the structure or function of the body, as the Food and Drug Administration (FDA) defines a drug, CBD is not classified as a narcotic drug. The Centers for Disease Control and Prevention (CDC) notes that CBD is not impairing, and the World Health Organization‘s Commision in Narcotic Drugs found that the chemical “has no potential for abuse and no potential to produce dependence.” Bissex adds that CBD has a good safety profile and is “generally well tolerated.”

Redd agrees that the chemical is well received by most users but says we still “lack long-term studies.” He adds that “the biggest concern with CBD is that the market is not fully regulated, and the quality and purity of CBD products can vary.” The CDC similarly notes a lack of regulation and says that because scientists are still learning about how CBD affects the body, it strongly suggests keeping CBD products “in childproof containers and out of the reach of children.”

The agency also warns adult users of potential harms and side effects associated with taking CBD products. These include liver damage, upset stomach, changes in one’s appetite, irritability and interference with other drugs one is taking that may cause more serious problems. Bissex says other side effects of using CBD products may also include “vivid dreams, fatigue and low blood pressure.”

—————————————————————————————————————————————————————————–

AllRightsReserved-InspirationalTechnologies2024

I hope this information was helpful and informative. If you have any more questions, please feel free to ask me. 😊

Inspirational Technologies – IT is Time

We, at Inspirational Technologies are at the forefront of Inspirational and Frontrunners on the frontier of current technology.

We are often faced with our own personal conflicts which directly influence our interactions with our peers and family.

Steven M Smith InspirationalTech.org CEO since 2013.

Thank you for consideration.

Inspirational Technologies

Category: Hemp News

A Decade of Hemp Innovation: Inspirational Technologies’ Journey and Next Chapter

2013–2015: Laying the Groundwork

2016–2018: Expanding into Hemp and Cannabinoids

2023 and Beyond: Embracing a New Frontier

Milestones and Future Goals at a Glance

More than a Decade of Innovation: Inspirational Technologies (2013–2025)

February 14, 2013, Inspirational Technologies